Sarepta Therapeutics, Inc. (SRPT) Earnings Per Share (EPS)
Sarepta Therapeutics, Inc. (SRPT) earnings per share history, EPS estimates, and growth trends. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2016-12-31 | -$5.49 |
| 2017-12-31 | -$0.86 |
| 2018-12-31 | -$5.46 |
| 2019-12-31 | -$9.71 |
| 2020-12-31 | -$7.11 |
| 2021-12-31 | -$5.15 |
| 2022-12-31 | -$8.03 |
| 2023-12-31 | -$5.80 |
| 2024-12-31 | $2.47 |
| 2025-12-31 | -$7.13 |
How SRPT compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| PODD | Insulet Corporation | $3.48 |
| BMY | Bristol-Myers Squibb Company | $3.46 |
| ALNY | Alnylam Pharmaceuticals Inc. | $2.33 |
| CVS | CVS Health Corporation | $1.39 |
| AMN | AMN Healthcare Services Inc | -$2.48 |
These are five companies in the same sector as SRPT with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Sarepta Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("SRPT")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | SRPT | $17.80 | +3.61% | 0.18M |
| 3 | ||||
| 4 | ||||
| 5 |